133 related articles for article (PubMed ID: 14664744)
1. Integrative tumor board: Advanced breast cancer.
Kut V; Boasberg P; Sagar S; Miller S; Birdsall TC; Rey S; Martin J; Rogers M; Wicke RW; Cheung CS; He B; Chen K; Hovi MA; Dreher H; McCray P; Block KI
Integr Cancer Ther; 2002 Jun; 1(2):179-214. PubMed ID: 14664744
[No Abstract] [Full Text] [Related]
2. Integrative tumor board: recently diagnosed lung cancer.
de la Torre M; Stolbach L; Fulop JA; Grotto D; Sagar SM; Hidenbrand G; Block KI
Integr Cancer Ther; 2002 Sep; 1(3):246-65. PubMed ID: 14667283
[No Abstract] [Full Text] [Related]
3. Integrative tumor board: Esophageal cancer.
de la Torre M; Bugno TJ; Gustin DM; Motwani B; Nathan D; Fulop JA; Augustine M; Lo CH; Yance DR; Krost B; Devi NJ; Little S; Block KI
Integr Cancer Ther; 2002 Mar; 1(1):44-66. PubMed ID: 14664748
[No Abstract] [Full Text] [Related]
4. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty.
Wasif N; Ye X; Giuliano AE
Ann Surg Oncol; 2009 Sep; 16(9):2442-9. PubMed ID: 19506955
[TBL] [Abstract][Full Text] [Related]
5. Integrative tumor board: recurrence of ovarian cancer.
Knaus JV; Bugno T; Nathan D; Lagomarcino N; Labriola D; Block PB; Alvarado C; Chamness A; Block KI
Integr Cancer Ther; 2002 Dec; 1(4):392-416. PubMed ID: 14664733
[No Abstract] [Full Text] [Related]
6. Quality indicators for the care of breast cancer in vulnerable elders.
Naeim A; Sawhney R; MacLean CH; Sanati H
J Am Geriatr Soc; 2007 Oct; 55 Suppl 2():S258-69. PubMed ID: 17910546
[No Abstract] [Full Text] [Related]
7. The philanthropic collaborative for integrative medicine: partnering for health and healing.
Horrigan B
Altern Ther Health Med; 2004; 10(1):82-3. PubMed ID: 14727504
[No Abstract] [Full Text] [Related]
8. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology.
Hirsch A
Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891
[No Abstract] [Full Text] [Related]
9. Eyelid swelling: an unusual presentation of metastatic lobular carcinoma of the breast.
El-Saify WM; Sherkawi EH; Rogers C
Breast J; 2005; 11(6):476-7. PubMed ID: 16297099
[No Abstract] [Full Text] [Related]
10. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
[TBL] [Abstract][Full Text] [Related]
11. Integrative tumor board: recurrent breast cancer or new primary? Integrative physician's perspective.
Block KI
Integr Cancer Ther; 2003 Sep; 2(3):301-5. PubMed ID: 15035895
[No Abstract] [Full Text] [Related]
12. Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report.
Zagouri F; Sergentanis TN; Koulocheri D; Nonni A; Bousiotou A; Domeyer P; Michalopoulos NV; Dardamanis D; Konstadoulakis MM; Zografos GC
World J Surg Oncol; 2007 Sep; 5():101. PubMed ID: 17848197
[TBL] [Abstract][Full Text] [Related]
13. [Use of complementary medicine and supportive care by breast cancer patients].
Mathelin C; Bagot JL
Gynecol Obstet Fertil; 2008 Mar; 36(3):245-7. PubMed ID: 18337150
[No Abstract] [Full Text] [Related]
14. A case of recurrent invasive lobular carcinoma of the breast found as metastasis to the duodenum.
Nihon-Yanagi Y; Park Y; Ooshiro M; Aoki H; Suzuki Y; Hiruta N; Kameda N; Katoh R
Breast Cancer; 2009; 16(1):83-7. PubMed ID: 18386118
[TBL] [Abstract][Full Text] [Related]
15. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
16. Metastatic breast cancer imitating acute diverticulitis.
Hamish IH; Paran H; Cohen D; Gutman M
Isr Med Assoc J; 2011 May; 13(5):321-2. PubMed ID: 21845979
[No Abstract] [Full Text] [Related]
17. Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.
Becker S; Becker-Pergola G; Wallwiener D; Solomayer EF; Fehm T
Breast Cancer Res Treat; 2006 May; 97(1):91-6. PubMed ID: 16319975
[TBL] [Abstract][Full Text] [Related]
18. Integrative tumor board: metastatic breast cancer.
Koch A; Ellis J; Gyllenhaal C; Tripathy D; Lo C; Oberbaum M; Samuels N; Singer SR; Gupta G; Block KI
Integr Cancer Ther; 2006 Dec; 5(4):373-90. PubMed ID: 17183755
[No Abstract] [Full Text] [Related]
19. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
Mihai R; Stevens J; McKinney C; Ibrahim NB
Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
[TBL] [Abstract][Full Text] [Related]
20. Integrative Tumor Board: pediatric synovial sarcoma.
Granowetter L; Ladas E; Taromina K; Rooney D; Kelly KM;
Integr Cancer Ther; 2006 Mar; 5(1):48-55. PubMed ID: 16578909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
